Cynosure Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $352K | Sell |
5,094
-4,710
| -48% | -$325K | 0.04% | 345 |
|
|
2025
Q1 | $681K | Sell |
9,804
-16,906
| -63% | -$1.17M | 0.09% | 114 |
|
|
2024
Q4 | $2.3M | Buy |
26,710
+19,003
| +247% | +$1.63M | 0.34% | 39 |
|
|
2024
Q3 | $918K | Sell |
7,707
-214
| -3% | -$25.5K | 0.13% | 77 |
|
|
2024
Q2 | $1.13M | Buy |
7,921
+496
| +7% | +$70.8K | 0.18% | 74 |
|
|
2024
Q1 | $953K | Buy |
7,425
+624
| +9% | +$80.1K | 0.17% | 68 |
|
|
2023
Q4 | $704K | Buy |
6,801
+248
| +4% | +$25.7K | 0.13% | 108 |
|
|
2023
Q3 | $596K | Buy |
+6,553
| New | +$596K | 0.18% | 104 |
|